IS3721A7 - Addition of benzimidazole, their form and their pharmacological use - Google Patents

Addition of benzimidazole, their form and their pharmacological use

Info

Publication number
IS3721A7
IS3721A7 IS3721A IS3721A IS3721A7 IS 3721 A7 IS3721 A7 IS 3721A7 IS 3721 A IS3721 A IS 3721A IS 3721 A IS3721 A IS 3721A IS 3721 A7 IS3721 A7 IS 3721A7
Authority
IS
Iceland
Prior art keywords
benzimidazole
addition
pharmacological use
pharmacological
Prior art date
Application number
IS3721A
Other languages
Icelandic (is)
Inventor
Elof Brändström Arne
Lennart Lindberg Per
Elisabeth Sundén Gunnel
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of IS3721A7 publication Critical patent/IS3721A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IS3721A 1990-06-20 1991-06-20 Addition of benzimidazole, their form and their pharmacological use IS3721A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (en) 1990-06-20 1990-06-20 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
IS3721A7 true IS3721A7 (en) 1991-12-21

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3721A IS3721A7 (en) 1990-06-20 1991-06-20 Addition of benzimidazole, their form and their pharmacological use

Country Status (27)

Country Link
EP (1) EP0535081A1 (en)
JP (1) JPH05507713A (en)
CN (1) CN1058212A (en)
AP (1) AP215A (en)
AU (1) AU649453B2 (en)
BG (1) BG97200A (en)
CA (1) CA2083714A1 (en)
CZ (1) CZ279772B6 (en)
FI (1) FI925766A7 (en)
HU (1) HUT62881A (en)
IE (1) IE912025A1 (en)
IL (1) IL98470A0 (en)
IS (1) IS3721A7 (en)
LT (2) LT3977B (en)
LV (1) LV10953A (en)
MA (1) MA22199A1 (en)
NO (1) NO924775D0 (en)
NZ (1) NZ238546A (en)
OA (1) OA09682A (en)
PT (1) PT98035A (en)
RO (1) RO110493B1 (en)
SE (1) SE9002206D0 (en)
TN (1) TNSN91049A1 (en)
TW (1) TW216418B (en)
WO (1) WO1991019711A1 (en)
YU (1) YU104191A (en)
ZA (2) ZA914296B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (en) * 1990-06-07 1990-06-07 Astra Ab IMPROVED METHOD FOR SYNTHESIS
SE9103776D0 (en) * 1991-12-19 1991-12-19 Astra Ab NEW COMPOUNDS
IS4232A (en) * 1993-12-06 1995-06-07 Astra Aktiebolag Substituted benzimidazole, its methods of manufacture and pharmacological use
SE504459C2 (en) * 1994-07-15 1997-02-17 Astra Ab Process for the preparation of substituted sulfoxides
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
WO2001062248A1 (en) 2000-02-24 2001-08-30 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (en) 2001-04-18 2001-04-18 Diabact Ab Composition that inhibits gastric acid secretion
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1492511B3 (en) 2002-04-09 2012-05-02 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
SE0203065D0 (en) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (en) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. Benzimidazole compounds
PL2046334T3 (en) 2006-07-25 2015-02-27 Vecta Ltd Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
WO2008047681A1 (en) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole compound having gastric acid secretion inhibitory activity
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (en) 2009-06-25 2012-03-27 아스트라제네카 아베 Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
EP3512840B1 (en) 2016-09-14 2024-03-06 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (en) 1974-02-18 1981-07-06 Haessle Ab ANALOGY PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH Gastric Acid Secretion Inhibitory Effects
SE416649B (en) 1974-05-16 1981-01-26 Haessle Ab PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion
IN148930B (en) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (en) 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (en) 1980-08-21 1984-07-13 Hoffmann La Roche IMIDAZOLE DERIVATIVES.
SE8300736D0 (en) 1983-02-11 1983-02-11 Haessle Ab NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
SE8301182D0 (en) 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (en) * 1985-10-29 1985-10-29 Haessle Ab NOVEL PHARMACOLOGICAL COMPOUNDS
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (en) * 1987-07-10 1989-01-19 Hoechst Ag SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF
AU2621888A (en) * 1987-10-30 1989-05-23 Aktiebolaget Hassle Omeprazole for treatment of diseases related to bone loss
AU2817989A (en) * 1987-12-11 1989-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
EP0415990A1 (en) * 1988-05-25 1991-03-13 Byk Gulden Lomberg Chemische Fabrik GmbH New fluoralkoxy compounds

Also Published As

Publication number Publication date
JPH05507713A (en) 1993-11-04
CS189491A3 (en) 1992-04-15
CN1058212A (en) 1992-01-29
FI925766A0 (en) 1992-12-18
ZA914296B (en) 1992-03-25
IE912025A1 (en) 1992-01-01
LTIP1712A (en) 1995-08-25
NO924775L (en) 1992-12-10
AP9100285A0 (en) 1991-07-31
MA22199A1 (en) 1992-04-01
RO110493B1 (en) 1996-01-30
LT3952B (en) 1996-05-27
LTIP1713A (en) 1995-08-25
TNSN91049A1 (en) 1992-10-25
TW216418B (en) 1993-11-21
AP215A (en) 1992-09-02
IL98470A0 (en) 1992-07-15
WO1991019711A1 (en) 1991-12-26
CA2083714A1 (en) 1991-12-21
CZ279772B6 (en) 1995-06-14
AU8009791A (en) 1992-01-07
FI925766A7 (en) 1992-12-18
BG97200A (en) 1993-12-24
NZ238546A (en) 1994-03-25
NO924775D0 (en) 1992-12-10
YU104191A (en) 1994-01-20
LV10953A (en) 1995-12-20
LT3977B (en) 1996-06-25
PT98035A (en) 1992-03-31
HU9204033D0 (en) 1993-03-29
AU649453B2 (en) 1994-05-26
EP0535081A1 (en) 1993-04-07
HUT62881A (en) 1993-06-28
SE9002206D0 (en) 1990-06-20
OA09682A (en) 1993-05-15
ZA914297B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
IS3721A7 (en) Addition of benzimidazole, their form and their pharmacological use
NO921863D0 (en) ANTIBODIES AND USES THEREOF
IS3660A7 (en) Medically active chloro-substituted benzimidazole, their method of manufacture and use
NO932176L (en) QUINOLINE, NAFTYRIDINE AND PYRIDOBENZOCSAZINE DERIVATIVES
ATE172477T1 (en) OLIGOMERS, THEIR USES AND FORMULATIONS
DE69133296D1 (en) speech
NO912589D0 (en) ANTI-PLACES AND ANTI-TUNSTEN DENTALS.
NO912344D0 (en) BENZOPURAND DERIVATIVES AND HETEROCYCLIC DERIVATIVES THEREOF.
NO932146L (en) benzimidazole
NO983400D0 (en) Oppfiskingsverkt ° y
TR24895A (en) DERIVATIVES OF PIRIMID, ITS ADMINISTRATION AND USE
NO914481D0 (en) PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS
DE69133085D1 (en) speech
DK4491D0 (en) ACLONIFEN-BASED HERBICID MIXTURES AND THEIR USE
FI923458A7 (en) 4,5-cycloalkano-3-benzazepin-7-ol derivatives and their use
IS4232A (en) Substituted benzimidazole, its methods of manufacture and pharmacological use
DK319387D0 (en) BENZIMIDAZOLE COMPOUNDS, THEIR PREPARATION AND USE
FI911510A7 (en) Hydroxymethylindolizidines and quinolizidines
ITMI912290A1 (en) MIXTURES OF N-ALCHYLPHTHALIMIDES, THEIR PREPARATION AND THEIR USE
FI941214L (en) Benzimidazole derivatives, their preparation and use
FI911989L (en) BLANKET AND PROCEDURE.
FI911084A7 (en) 5-phenyl-1H-pyrazole-4-propionic acid derivatives, their preparation and use
DE59107173D1 (en) LOCAL ANESTHETIC
SE9001396D0 (en) MOVING CONSTRUCTION CONSISTING OF MOVING CONNECTED, EXTENSIVE SECTIONS AND MOVING CONNECTION FOR USE IN CONSTRUCTION
DK8690D0 (en) CONNECTIONS AND USE